Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
1.330
+0.210 (18.75%)
At close: Sep 15, 2026, 4:00 PM EDT
1.200
-0.130 (-9.77%)
Pre-market: Sep 16, 2026, 6:30 AM EDT
Biodexa Pharmaceuticals Employees
Biodexa Pharmaceuticals had 11 employees as of December 31, 2025. The number of employees decreased by 2 or -15.38% compared to the previous year.
Employees
11
Change (1Y)
-2
Growth (1Y)
-15.38%
Revenue / Employee
n/a
Profits / Employee
-$533,127
Market Cap
1.37M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11 | -2 | -15.38% |
| Dec 31, 2024 | 13 | -8 | -38.10% |
| Dec 31, 2023 | 21 | -6 | -22.22% |
| Dec 31, 2022 | 27 | 7 | 35.00% |
| Dec 31, 2021 | 20 | 2 | 11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Jaguar Health | 47 |
| Scinai Immunotherapeutics | 45 |
| Virax Biolabs Group | 26 |
| Silexion Therapeutics | 14 |
| Decoy Therapeutics | 11 |
| Oragenics | 3 |
| Bone Biologics | 2 |
BDRX News
- 22 hours ago - Biodexa Enters Into Warrant Exercise Transaction for $2.3 Million in Gross Proceeds - GlobeNewsWire
- 4 days ago - Interim results for the six months ended June 30, 2026 - GlobeNewsWire
- 27 days ago - Biodexa recruits 87 of 168 subjects in Serenta Phase 3 eRapa polyposis trial - TheFly
- 27 days ago - Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP - GlobeNewsWire
- 6 weeks ago - Biodexa Pharmaceuticals Registration statement: Registration filing - Filings
- 6 weeks ago - Result of General Meeting - GlobeNewsWire
- 6 weeks ago - Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France - GlobeNewsWire
- 2 months ago - Biodexa Pharmaceuticals Registration statement: Registration filing - Filings